Shares of Zydus Lifesciences saw a decline of more than two percent following the announcement of a notable profit drop. The net profit plunged thirty-six percent year-on-year for the first quarter, despite a nearly twenty-two percent increase in operational revenue. Expenses surged by over forty-one percent. However, the managing director remains optimistic about future prospects. Analysts at Nuvama have upgraded the stock to ‘Buy’, setting a higher price target.
United Breweries shares rally 14% after Q2FY27 profit jumps 191% YoY
United Breweries shares surged by 14.44% as the company announced a staggering 191% jump in net profit, now at Rs 135 crore for the September
October 28, 2026